TP53 and diabetes mellitus: Elsewhere, studies showed that the SAC pretreatment of streptozotocin-infused mice (an animal model of diabetes) drastically improved cognitive function, antioxidant capacity (measured by GSH, GPx, and glutathione reductase levels) and prevented apoptosis (assessed by DNA damage and Bcl-2 and p53 expression) [469].